{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "EFPIA’s Response to EU Pharmaceutical Strategy Consultations",
    "url": "https://www.lexblog.com/2022/07/04/efpias-response-to-eu-pharmaceutical-strategy-consultations/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-2YRFQPJ2",
        "url": "https://www.lexblog.com/lib/2YRFQPJ2/"
    },
    "datePublished": "2022-07-04T06:57:28-04:00",
    "dateModified": "2022-07-04T04:02:16-04:00",
    "author": {
        "@type": "Person",
        "name": "Alexander Roussanov, Sofia Wilson"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Arnold & Porter Kaye Scholer LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "BioSlice Blog",
    "about": "Business and Commercial · Health Care and Life Sciences",
    "sourceUrl": "https://www.biosliceblog.com/?p=3098",
    "sourceStability": "may-move"
}